PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FAS9F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,605
Award facts
- Contract value 100% obligated
- $16,605.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,605.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of September 23, 2025. The delivery order represents a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. This prime contract enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its critical role as a vendor for military and veteran healthcare procurement, with a proven track record of fulfilling competitively awarded delivery orders across varying transaction values. The company serves customers including the Defense Health Agency and U.S. Coast Guard, leveraging its comprehensive contract vehicle to meet diverse pharmaceutical and medical supply requirements. The DLA Medical Supply Chain's strategic approach to pharmaceutical procurement, which includes planning for multiple regional awards under the upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts, underscores the continued importance of reliable, capable distributors like AmerisourceBergen in supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2D825FAS9F?
SPE2D825FAS9F was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2D825FAS9F worth?
The government has obligated $16,605 on SPE2D825FAS9F.
Is contract SPE2D825FAS9F an order under another contract?
Yes. SPE2D825FAS9F is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D825FAS9F competed?
The extent of competition for SPE2D825FAS9F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award